APA (7e ed.) Bronvermelding

Nielsen, N., Galsgaard, E., Ahern, D., Andersen, M., Spee, P., Feldmann, M., . . . Soederstroem, K. (2012). BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-MEDIATED CYTOTOXICITY.

Chicago (17e ed.) Bronvermelding

Nielsen, N., E. Galsgaard, D. Ahern, M. Andersen, P. Spee, M. Feldmann, F. Brennan, en K. Soederstroem. BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-MEDIATED CYTOTOXICITY. 2012.

MLA (9e ed.) Bronvermelding

Nielsen, N., et al. BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-MEDIATED CYTOTOXICITY. 2012.